Tempus Shares Jump After Strong Preliminary 2025 Results [Yahoo! Finance]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
The filing shows full-year revenue up about 83% year-over-year, with diagnostics revenue near $955 million and data and applications at about $316 million. Tempus reported fourth-quarter revenue around $367 million, also up roughly 83%. Warning! GuruFocus has detected 5 Warning Signs with TEM. Is TEM fairly valued? Test your thesis with our free DCF calculator. Management highlighted total contract value above $1.1 billion as of Dec. 31 and a net revenue retention rate of about 126%, signaling expanding customer spend. The company said teams signed data agreements with more than 70 clients, naming major pharma and biopharma partners such as AstraZeneca ( NASDAQ:AZN ), GlaxoSmithKline ( NYSE:GSK ), Bristol Myers Squibb (BMY), Pfizer ( NYSE:PFE ), Novartis (NVS) and Merck ( NYSE:MRK Investors will watch Tempus's ( NASDAQ:TEM ) presentation at the J.P. Morgan Healthcare Conference for color on 2026 demand, pricing and margins. Market watchers also note the U.S. consumer pric
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- AstraZeneca (NASDAQ:AZN) had its "sell" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.MarketBeat
- What Makes AstraZeneca (AZN) a Strong Growing Company? [Yahoo! Finance]Yahoo! Finance
- AstraZeneca Spotlights 2025 Growth, 2026 Launch Wave and $80B 2030 Goal at JPM Conference [Yahoo! Finance]Yahoo! Finance
- Astrazeneca (AZN) Ascends While Market Falls: Some Facts to Note [Yahoo! Finance]Yahoo! Finance
- JPM26: AstraZeneca bids to accelerate oncology R&D with Modella AI acquisition [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 1/8/26 - Form 6-K
- 1/2/26 - Form 6-K
- 12/22/25 - Form 6-K
- AZN's page on the SEC website